Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Invida to Market Three Dermatology Products in China

publication date: Jan 12, 2010
Invida Group of Singapore announced plans to launch three dermatological brands in China: Dermatix®, Zalain® and Kinerase®. Invida, though mainly a commercialization company, also has proprietary products. With 13 subsidiaries and more than 3,700 employees, Invida was established as a Joint Venture in 2005 by Temasek Holdings, Quintiles Transnational and the Zuellig Group. Earlier entities have been providing commercialization services in Asia Pacific for more than 50 years. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here